New research underscores benefits of gender-affirming hormones, rebutting anti-trans claims
Anti-trans legislation and rhetoric frequently suggest that taking gender-affirming hormones is a big health risk. But at the annual meeting of the Endocrine Society last week, researchers presented swaths of evidence on the benefits of gender-affirming hormones and the harms of trans discrimination, with the hopes of combating unscientific opposition.
“It’s very motivating to me to actually provide the evidence to show the benefits of hormones that I see every single day,” said Brendan Nolan, an Australian clinician and researcher at the University of Melbourne (Austin Health). At the meeting, Nolan presented what he says is a “world-first” randomized clinical trial on the benefits of gender-affirming hormones.
